Article info
PDFClinical science
Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
- Correspondence to Dr Mario Romano, Dipartimento di Scienze per la Salute, Via F De Sanctis, 86100 Campobasso, Italy; romanomario{at}email.it
Citation
Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
Publication history
- Accepted November 4, 2009
- First published December 3, 2009.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2009, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.